NCT00674583 - Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children | Biotech Hunter

Enrollment

414

Participants

Timeline

Start Date

May 9, 2008

Primary Completion Date

September 2, 2008

Study Completion Date

January 8, 2009

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL

GSK Biologicals' meningococcal vaccine GSK134612

Intramuscular administration, 1 dose

BIOLOGICAL

Menjugate

Intramuscular administration, 1 dose

Trial Locations (31)

10315

GSK Investigational Site, Berlin

10627

GSK Investigational Site, Berlin

13055

GSK Investigational Site, Berlin

14197

GSK Investigational Site, Berlin

32339

GSK Investigational Site, Espelkamp

32457

GSK Investigational Site, Porta Westfalica

32479

GSK Investigational Site, Hille

32756

GSK Investigational Site, Detmold

37000

GSK Investigational Site, Tours

42551

GSK Investigational Site, Velbert

42579

GSK Investigational Site, Heiligenhaus

42719

GSK Investigational Site, Solingen

47574

GSK Investigational Site, Goch

54290

GSK Investigational Site, Trier

55131

GSK Investigational Site, Mainz

67227

GSK Investigational Site, Frankenthal

67380

GSK Investigational Site, Lingolsheim

69120

GSK Investigational Site, Vaulx-en-Velin

75015

GSK Investigational Site, Paris

76600

GSK Investigational Site, Le Havre

81241

GSK Investigational Site, Munich

81735

GSK Investigational Site, Munich

82140

GSK Investigational Site, Olching

83300

GSK Investigational Site, Draguignan

86720

GSK Investigational Site, Nördlingen

88069

GSK Investigational Site, Tettnang

02000

GSK Investigational Site, Laon

01700

GSK Investigational Site, Miribel

06300

GSK Investigational Site, Nice

06700

GSK Investigational Site, Saint-Laurent-du-Var

06140

GSK Investigational Site, Vence